NCT02155127

Brief Summary

Chronic kidney disease (CKD) affects more than 26 million individuals (13 percent) of the U.S. population, with a projected 70 percent increase by the year 2015 to over 40 million individuals. Impairments in physical function and mobility limitations have been reported in older Chronic Kidney Disease patients, however the consequences of impaired functioning on participation in daily life and quality of life have not been studied. Early identification and interventions to mitigate deterioration in physical function and mobility should lead to improved health and quality of life outcomes in older patients with Chronic Kidney Disease. Although older individuals with Chronic Kidney Disease have reduced survival expectancy, maintaining physical function and mobility may contribute to longer active life expectancy, and higher quality of life despite their diagnosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 2, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 4, 2014

Completed
4 months until next milestone

Study Start

First participant enrolled

October 1, 2014

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

November 18, 2016

Status Verified

November 1, 2016

Enrollment Period

2 years

First QC Date

June 2, 2014

Last Update Submit

November 16, 2016

Conditions

Keywords

chronic kidney diseasephysical function

Outcome Measures

Primary Outcomes (1)

  • walking speed

    baseline to 3 months

Study Arms (2)

walking intervention

EXPERIMENTAL

Subjects are randomized to walking/functional strength program with weekly coaching or usual care. The program is for 12 weeks. The intervention includes 3 lower extremity strengthening exercises, and progressive walking.

Behavioral: walking

usual care

NO INTERVENTION

these subjects receive information on walking program, however do not receive any coaching over 12 weeks

Interventions

walkingBEHAVIORAL
walking intervention

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female patients over the age of 60 years
  • Diagnosed with moderate to severe CKD (stage 2-4)
  • Ambulatory (with or without use of an assistive device such as a cane or walker)
  • Living in the community, cognitively able to provide consent and understand directions for the tests
  • Cognitive ability to understand and carry out an independent home walking program
  • Access and ability to communicate with study staff on a weekly basis and available for follow-up testing.

You may not qualify if:

  • Inability to carry out a program of walking independently at home
  • Unavailable for follow-up testing, estimated GFR \>60 ml/minx1.73m2 and \< 15 ml/minx1.73 m2
  • Recent cardiac event (within the past 6 months)
  • Uncontrolled hypertension
  • Uncontrolled diabetes
  • Pulmonary disease that may limit the ability to progress with walking
  • Progressive neuromuscular disease
  • Any orthopedic or neuromuscular condition that may be exacerbated by increased walking activity
  • diabetic foot ulcer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Utah

Salt Lake City, Utah, 84112, United States

Location

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Interventions

Walking

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

LocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Officials

  • Patricia L Painter, Ph.D.

    University of Utah

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Research Faculty

Study Record Dates

First Submitted

June 2, 2014

First Posted

June 4, 2014

Study Start

October 1, 2014

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

November 18, 2016

Record last verified: 2016-11

Locations